The FDA has announced that the hearing on the safety of Hemopure will take place behind closed doors. The reason given by the FDA for closing the hearing from public view is "trade secret and/or confidential information".
Surprisingly, Biopure, the maker of Hemopure, does not understand why the hearing will be closed as they have "no objection to holding an open hearing".
Does the FDA feel so tarnished by its actions re blood substitutes that it is afraid to let the public in on the hearing for another blood substitute?
No comments:
Post a Comment